Skip to main content
Premium Trial:

Request an Annual Quote

Functional Genomics Co. BioSource Appoints New CEO

NEW YORK, Sept. 26 – Functional genomics company BioSource International said Wednesday it had appointed Leonard Hendrickson president and CEO.

Until now, Hendrickson has been serving as the president and director of Isotope Products Laboratories. He has also been a director of BioSource of Camarillo, Calif., since 1993.

Hendrickson will replace James Chamberlain, the company’s founder and former president and CEO, who returned from retirement in May to serve as interim CEO.

Hendrickson said his first task would be to jumpstart sales for the company. 

"My first job will be to strategically position the company for accelerated top-line growth,” Hendrickson said in a statement.

BioSource develops reagent systems for genomics and proteomics that are designed to facilitate the discovery of new treatments.

Hendrickson will assume the duties of CEO on October 15.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.